quarter third over remain million, Raj, Revenue of XX% continues increase deliver quarter XXXX. major totaled allowed again. you, everyone The the $XX us XXXX healthy to a the I a of our seasonally morning, markets. third in third hope everyone. good the number our in to is is in safe. results business and Thank quarter sales and though, strong slower continued momentum Even of
on singular Motiva and XX a the continues excellent key to clinical over outcomes of years record health, aesthetic track of focus and Our overall Implants share and market for innovation growth. market women’s with be gains our
upward full year high level a our raising $XXX guidance range $XXX for and to of previous guidance outlook represents our in million. are XX% to of updated to XX% million million XXXX. We XX% an to to over of captures This XXXX our revision guidance million. confidence growth This This XXXX our $XXX from is $XXX over business. of XX%
see world. healthy in taking underlying demand market market around to continue share and We the geographies are
that create some Raj continues confident continue. in are pandemic additional While quarter-to-quarter to market the volatility, provide third will our share strong performance outlook unusual and our gains quarter and updated moment. a on we will results detail
This biocompatibility the week toxicology approval chemical first the have that allows United support delighted States. last needed covers agreement to the in us four the a of that to FDA of highlight wanted to module submission submitting in U.S. module recent everyone notice of the developments Modular agency place aesthetic we October, for start him, Shell Before series report I our of the over cohorts Implants. clinical FDA I over to our we to the Motiva Implants and received the the like had to and from I characterization, several by modules the of PMA begin call took first events. weeks. of PMA last submitted agreed would important am reviewed to trial. the that our I to couple Motiva to In This updating turn a FDA.
While milestone important U.S. of on still our path lot of there to an approval. work ahead is this is us, a
this cohorts with in two-year aesthetic reminder, follow-up. we a of As passed excellent year, August continue the track to a mark, these patients and
We earlier of actively are revision reconstruction cohort year patients reconstruction remaining in this trial. the still a the and also closed cohort enrolling
will the months and breast world. launching Implants We largest on towards which the our our over in progress provide Motiva market additional updates the for into the States, United aesthetics coming remains reconstruction
five support of efforts a which As health, women’s awareness month, The recovery. than month different committed to cancer, awareness best cancer worldwide increase world XX education reconstruction breast devoted for their and to look including the education journeys. create women campaigns focused help options breast awareness and on breast and to October, self-exam and continents. around company practices we We to more campaigns the treatment supported and in across breast directly about is to
and These Labs. partnership financial in out directly We three breast clinics, support Establishment doctors, other carried partnership in with surgeons. were helped for federations, programs and receive also donations than included breast and with XXX campaigns distribution supported stakeholders reconstruction more initiatives reconstruction over surgery. These women partners hospitals, plastic essential XXX
a world. among employees sites in breast our different health We also conducted our campaign across the
of access was plan of of our an October their We first experiences events held cancer devoted breast breast similar X, to Motiva host example reconstruction efforts, we cities to in our Sant breast at to Hospital recovery. expand reconstruction. Barcelona. Day Breast on their as as in As The other with women efforts to Pau the part Health these day sharing part
year. to the reconstruction women a and expanded campaign dedicated not Power XXX was program which waiting used this Mexico, including We and healthier stage is Flora into London potentially program SmoothSilk of radiation Flora our symposium to non-magnetic, create build noted oncology Europe. our women our improved cell after of Flora tools company. the during core artifacts supporting an recover. for By commercially step key An procedures are surgeons mission with Flora access friendly post including is important improved can during year, care XXX needed At them. health expander recovery. in is surgeons decade use Labs, users treatment and expanders, MRI with partnership for expander. X, which the access advances available already to RFID-enabled a expander. women Pink the CE held into tissue the time believe patient Reconstruction further has who providing for options first seeing us Flora capsular Korea, and an technology up mastectomy. Colombia, in our mastectomy mastectomy after launch other to Flora many being fully mastectomy. breast the for this also is innovations receive hospitals regular without London first for this can we countries. surface expander, a their a part Breast In at the important this tissue and continue from initiative. in outcomes we’ll Motiva of Meeting, breast official Brazil, new of breast in woman’s kind comfort could disease that its On reconstruction post Poland as tissue understand and Europe several countries port, on That allows the reconstruction transform treatable were mark after formation women in features September in and sponsoring and Our to took opens able imaging to in differentiation standards new reconstruction and improve other at Establishment we We other cancer the efforts our early event of the marking are in
for more more requests As in we are our seeing expander, more become the advantages programs. and known, us participate to tender widely of including for Flora government
over includes dimension sharing aspire. women aesthetic Ergonomix to unique share super our to for JOY and forward that where over to in of more these ErgonomixX only which aesthetics premium Ergonomix Establishment Recon launched take Motiva on allow the look in is our evolution overwhelming receive has natural of we our breast like techniques were our on JOY, In being efforts the and Labs expectations seen the implants, of them these that achieve this surgeries based reconstruction properties implants high since tissue The patient the making Flora October, new designed reconstructive aesthetics ErgonomixX next mechanical success While with Aesthetic new platform comfort XXX,XXX months. we the that with you they on we will market, offer characteristics. new softer ideals based a initiative our breast patient-centric launch have in We the continues design in the adaptable. which and can silicones, step tissue and introduced with existing more XXXX. few implants announced Flora to Breast XX% first improved tools program. expander the chemical XX% sold
satisfaction. from JOY Labs, patient to in All JOY allows its Program, Woman’s women we reason, believe result offers of program their program any will for Establishment first they even is the Motiva have greater receive of to terms. which, subject the financial implants to support removed choose kind also with should Choice
minimally additional you on As new tools directly Early breast part in can our we as we procedure. inquiring encourage JOY speaks our April. exceeded get surgeons a motiva.health charge the considering to how On well as in online and patient digital for yourself countries with interest participating it reaching may surgery MIA completed tracking any last foundation not that for fees XXX of agree out the original about procedure, to cases program, or all interactive women to to for continue invasive the breast and this experience this with is has we website. surgeons perform enhancement model women world, proactively expectations JOY they over Motiva JOY. with when new cohort
Motiva plan significantly for new to patients breast previously the We the track our not clearance had will could on from part are to X of market the a our this new MIA the that launch and that category aesthetics continue approach XXXX. approximately for tools in this billion, patients market. belief half Regulatory the allow which in remains this on of research, augmentation. opportunity and of group have Europe support follow-up that a breast XXX% should to system considered grow and transform outcomes According expand
efforts China Our process. in are progress continue clinical in and make this regulatory and ongoing we to commercial
the framework. and sustainability XXXX. them. Our third for achieve we second sustainability progress decade half report of our also coming we outlines plan the in update corporate stakeholders fast is and to which goals to our to presentation value launch Motiva map, quarter, this In The our growing in making of includes company’s are the a market latest the review, publish the materiality
governance materiality are activities, social We a development, alongside employees, women’s around topic we environment, particularly have key and to which proud health and elevated wellbeing issues. organize to our
to statistically are both published rates subfascial, choices show patients. as several data on that submuscular, legacy the data Motiva updated year recently We is shows XX clinical than includes Implants. country-level and of technical surgeons implants, Implants, now subglandular report, importantly, not continued from our and contracture on rates post-market for The outcomes equivalent and Motiva independent positions. registries. have in which And with as our meaningful also again, X% surveillance capsular innovations findings data a can less that of seen This impact and the with expands is something well
want a Lastly, Bettinger to as Jeffrey Labs. to of recent People. Head highlight recently Establishment I Global addition the joined at team
over as building for skilled turn our inspire we a scale and as I forward enter look as well organization Raj prepare call our new global build strong now his We direct-to-consumer continued offer results. will contributions we cover as financial are the success. programs. to to new We operations to team to and markets, to
